News Boundless Bio raises $100m for circular DNA cancer therapy Boundless Bio’s plans to develop a new class of cancer therapies targeting DNA found outside the nucleus of malignant cells have been boosted by a $100 million fundraising
R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations.
Events Partner Content Oligonucleotide Therapeutics and Delivery Conference Oligonucleotide Therapeutics and Delivery
Digital Developing with start-up DNA As head of digital at Sandoz, Andre Heeg is at the forefront of transformation both within his company and the wider industry.
News NHS records to be harnessed in pancreatic cancer screening The NHS has started a pilot project that will sift through patient records to try to detect people at risk of pancreatic cancer.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face